Select Medical Holdings Co. (NYSE:SEM) Shares Sold by Price T Rowe Associates Inc. MD

Price T Rowe Associates Inc. MD lessened its position in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 0.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,484,810 shares of the health services provider's stock after selling 30,230 shares during the quarter. Price T Rowe Associates Inc. MD owned about 13.50% of Select Medical worth $329,589,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in SEM. Norges Bank acquired a new stake in Select Medical during the 4th quarter worth $29,556,000. Invesco Ltd. grew its stake in Select Medical by 48.6% during the 4th quarter. Invesco Ltd. now owns 2,643,943 shares of the health services provider's stock valued at $49,838,000 after acquiring an additional 864,852 shares in the last quarter. Empowered Funds LLC acquired a new stake in Select Medical in the 4th quarter valued at about $5,903,000. Raymond James Financial Inc. acquired a new position in shares of Select Medical during the 4th quarter worth approximately $5,858,000. Finally, Renaissance Technologies LLC grew its position in shares of Select Medical by 1,206.4% in the fourth quarter. Renaissance Technologies LLC now owns 305,700 shares of the health services provider's stock valued at $5,762,000 after purchasing an additional 282,300 shares in the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Select Medical Stock Performance

Shares of SEM traded up $0.10 during mid-day trading on Thursday, reaching $18.34. 356,477 shares of the company's stock were exchanged, compared to its average volume of 833,387. The business's fifty day simple moving average is $17.02 and its 200-day simple moving average is $22.07. Select Medical Holdings Co. has a 52-week low of $14.99 and a 52-week high of $40.98. The stock has a market capitalization of $2.37 billion, a PE ratio of 11.11, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.50 billion. On average, equities research analysts expect that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 13th. Investors of record on Monday, March 3rd were paid a $0.0625 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.36%. Select Medical's dividend payout ratio (DPR) is presently 15.15%.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. Mizuho started coverage on Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 target price for the company. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. Royal Bank of Canada reduced their price target on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a research report on Monday, February 24th. Benchmark raised Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a research note on Monday, February 24th. Finally, UBS Group decreased their target price on shares of Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a research report on Friday, January 3rd. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $26.80.

Insider Transactions at Select Medical

In other news, CEO David S. Chernow sold 225,000 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the completion of the transaction, the chief executive officer now directly owns 714,516 shares of the company's stock, valued at $12,861,288. This trade represents a 23.95 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 11.60% of the company's stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.